3AM Stock Chart & Stats
€31.60
-€0.40(-1.12%)
At close: 4:00 PM EDT
€31.60
-€0.40(-1.12%)
Day’s Range― - ―
52-Week Range€15.00 - €43.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€1.71B
Enterprise Value€2.66B
Total Cash (Recent Filing)€400.79M
Total Debt (Recent Filing)€979.41M
Price to Earnings (P/E)46.4
Beta0.36
Next Earnings
Nov 05, 2026EPS Estimate
0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.83
Shares Outstanding49,604,366
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-1.09
Price to Book (P/B)1.56
Price to Sales (P/S)0.38
P/FCF Ratio11.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€46.56Price Target Upside47.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)1.25
Revenue Forecast (FY)€3.57B
Bulls Say, Bears Say
Bulls Say
Rapid Revenue And EBITDA GrowthStrong year-over-year revenue and EBITDA growth indicates expanding demand for Astrana’s value-based care platform and improving operating scale. If sustained, this growth can support further investment in provider capabilities, technology, and market expansion while strengthening the company’s competitive position.
Strong Cash Generation And DeleveragingMeaningful free cash flow and accelerated debt repayment improve financial flexibility and reduce balance-sheet risk. Continued internal cash generation can fund growth initiatives, support integration spending, and lower reliance on external financing as Astrana expands its provider and payer relationships.
Scaled Full-Risk Value-Based PlatformA large membership base and high full-risk mix deepen Astrana’s exposure to value-based care economics, where effective cost and quality management can produce recurring contract returns. Scale also supports data advantages, provider engagement, and more efficient care coordination across markets.
Bears Say
Severe Margin CompressionThe sharp decline in gross and net margins shows that rapid revenue growth has not translated proportionately into earnings quality. Persistently thin profitability leaves less cushion for medical-cost volatility, contract underperformance, or investment needs and may constrain the cash available for expansion.
Debt Coverage Remains ThinAlthough Astrana is generating cash and repaying debt, operating cash flow still covers only a modest portion of total debt. If cash generation weakens because of medical-cost pressure or slower growth, the company could have less flexibility for acquisitions, investment, and other strategic commitments.
Medicaid Membership AttritionSustained Medicaid membership losses can reduce the scale of Astrana’s contracted populations and disrupt the economics of its provider and risk arrangements. Rebalancing toward full risk may help, but ongoing attrition could pressure revenue visibility, network utilization, and near-term operating leverage.
3AM FAQ
What was Astrana Health’s price range in the past 12 months?
Astrana Health lowest stock price was €15.00 and its highest was €43.40 in the past 12 months.
What is Astrana Health’s market cap?
Astrana Health’s market cap is €1.71B.
When is Astrana Health’s upcoming earnings report date?
Astrana Health’s upcoming earnings report date is Nov 05, 2026 which is in 22 days.
How were Astrana Health’s earnings last quarter?
Astrana Health released its earnings results on Aug 06, 2026. The company reported €0.358 earnings per share for the quarter, beating the consensus estimate of €0.301 by €0.057.
Is Astrana Health overvalued?
According to Wall Street analysts Astrana Health’s price is currently Undervalued.
Does Astrana Health pay dividends?
Astrana Health does not currently pay dividends.
What is Astrana Health’s EPS estimate?
Astrana Health’s EPS estimate is 0.41.
How many shares outstanding does Astrana Health have?
Astrana Health has 49,604,366 shares outstanding.
What happened to Astrana Health’s price movement after its last earnings report?
Astrana Health reported an EPS of €0.358 in its last earnings report, beating expectations of €0.301. Following the earnings report the stock price went up 0.658%.
Which hedge fund is a major shareholder of Astrana Health?
Currently, no hedge funds are holding shares in DE:3AM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Astrana Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€46.56 (47.33% Upside)
€46.56 (47.33% Upside)
Blogger Sentiment
Bullish
DE:3AM Sentiment 75%
Sector Average 67%
Sector Average 67%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
31.91%
12-Months-Change
Fundamentals
Return on Equity
5.09%
Trailing 12-Months
Asset Growth
58.22%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Astrana Health
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
3AM Company Deck
3AM Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: substantial year-over-year top-line and profitability growth, improved operating leverage from AI-driven automation, meaningful cash generation and accelerated de-leveraging, successful integration of Prospect with expected synergies, and raised EBITDA guidance. Offsetting these positives are ongoing Medicaid membership attrition and program-specific headwinds in California, slightly elevated commercial cost trends, a minor one-time $15 million ACO REACH revenue reduction, and some uncertainty around exchange and Medicaid dynamics. On balance, the positive execution, scale gains, and trajectory of the AI-native operating system materially outweigh the near-term challenges and conservatively guided risks.View all DE:3AM earnings summaries3AM Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€46.56
▲(47.33% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Clinigence Holdings
―
InnovAge Holding
―
Agilon Health
―
Aveanna Healthcare Holdings
―
P3 Health Partners
―









